POPULARITY
Categories
Thank you for joining us for our 2nd Cabral HouseCall of the weekend! I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks… Becca: Hi Dr. Cabral! My husband is challenged by a "cobalt conundrum". Several years back he was overexposed to wet cement, spending hours mixing it with his hands. (Big mistake) Shortly after he developed a severe body rash along with painful cramps and diarrhea. After many tests, they found an allergy to cobalt via a skin test, and we assume it relates to the cement mixing incident. Severely limiting cobalt both topically and in diet has helped, but he still struggles with GI issues. Functional medicine tests showed leaky gut. He attempted treatment but even one basic supplement (dairy free igg) caused severe stomach issues. Meanwhile he's missing vital nutrients from avoiding b12 (cobalt) etc. How can he address leaky gut and allergies when he's so sensitive to treatments? Signed, Your Fan Ally: Hi Dr. Cabral, I am a new Level 2 graduate and I have a new client who is 20-years old with a history of anorexia. she is 5-years post treatment. She complains of bloating, constipation, and just having trouble eating. She is of normal weight, and is looking for relief. I was thinking of doing the Big 3 labs and the CBO protocol.. Any recommendations would be very appreciated. I do not want to recommend the wrong plan of care for her. Warmest regards, Ally :) Tommy: Hey Dr. C, I'm an IHP, 36. Had a birth defect, 3 operations by the age of 8 including tonsillectomy. Sleep issues began at 9, insomnia by 12, eczema, fainting, 14 years of steroid creams and thousands of antibiotics. I've got high heavy metals and Citrabacter freundi. I can't tolerate any protocols even at a lower dose, they make my existing problems worse. On days where I train intensely I struggle to shut off. I feel like my body is always stuck in a low level of stress. I've cut down my training a lot but I'm not sure what else I can do. I'm tolerating zinc Carnosine which helps but I still always have red skin on my face. Still struggle to tolerate stress. If only I could do a heavy metal protocol. Sarah: Hi! Hope you are well and love tuning in daily to learn from you! I have been trying to heal leaky gut and chronic hives for over a decade now. Because I am very reactive I stop and start a lot. However, I recently gave in and started a low dose prednisone and over a couple weeks lost 10lbs of inflammation, hives gone, that I couldn't break with any diet (restriction), exercise etc. I would like to do some testing and do the CBO protocol as this started after antibiotics. My question is, will this skew the results of cortisol/A1C and will it be okay to continue on to keep symptoms calm while getting to the root and going through some protocols? Thanks! (BTW) I have tried all the natural stabilizers and didn't help calm symptoms. (Quercetin, Vit C, Mag, etc) Sienna: Hi Dr. Cabral, this is a follow up to my question on 3782 re testing for perimenopause please. Thank you for your guidance and if I could run EL labs I would. I have NO access to Saliva Testing in my country (and EL don't ship here). So I know about SMM & Fertility Labs but can't run them so I am *specifically* asking IF estrogen & progesterone tested by an endocrinologist (BLOOD) have ANY value as a way to look at levels? LH, FSH & AMH are great as I can get these from bloods, can you please provide the healthy ranges vs. perimenopause? Would really appreciate it as this is the only option I have to look deeper & PCP here don't have a functional approach so really value your guidance on anything you can share to help me support my body. Thank-you, Sienna Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right! - - - Show Notes and Resources: StephenCabral.com/3817 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!
Diagnosed at ten, Kaitlyn runs most of her own care a year later with an A1C in the fives. She and mom Jen show what calm, informed type 1 looks like. ABLEnow save for today's needs or invest for tomorrow Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof. ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Kate Makinson has lived with Type 1 diabetes since 7th grade and has spent the last 33 years building a life of absolute adventure. She's a PE teacher, runner, mountain biker, and someone who has always found a way to figure it out, whether that meant finishing a half marathon with a failing CGM or managing nine days in Europe after her insulin pump broke with nothing but short-acting insulin.After 12 years away from the diabetes community, raising two kids and focusing on her career, things started changing. When perimenopause hit, the symptoms looked so much like long-term diabetes complications that Kate convinced herself that was exactly what they were. That fear, after three decades of managing T1D with confidence, sent her looking for a T1D community she'd never thought she needed. She found it in Risely's group coaching program, where her average blood sugar dropped from 171 to 155, her time in range climbed from 61% to 75%, and her A1C improved from 7.5 to 6.9. But more than the numbers, Kate walked away with a mindset she hadn't had in years: that no matter what diabetes throws at you, you've got this.WHAT WE COVER:The specific habit that helped drop her average blood sugar from 171 to 155 and bring her time in range from 61% to 75%What it was like to spend nine days in Europe after her insulin pump broke with nothing but short-acting insulin, and how she managed to keep adventuring anywayHow a failing CGM in the first mile of a half marathon forced her to run 13 miles on instinct, gels, and sheer determinationWhy perimenopause symptoms convinced her she had long-term diabetes complicationsWhat brought her to Risely coaching after 33 years of managing T1D largely on her own, and why she says it was the support she didn't know she neededHer best travel tips for flying, international trips, and staying prepared without letting diabetes overthink the adventureWHAT'S NEXT:
Metformin is one of the most commonly prescribed medications for type 2 diabetes and prediabetes, but did you know it can increase the risk of vitamin B12 deficiency? In this episode, Dr Jedha explains why this happens, the symptoms to watch for, and when it's worth talking to your doctor about a simple vitamin B12 blood test.You'll also hear two inspiring member stories showing how sustainable nutrition and lifestyle changes helped improve blood sugar, lower A1c, and avoid or stop medication. Whether you're taking metformin or simply want to better understand your treatment options, this episode provides practical, evidence-based insights to help you make informed decisions about your diabetes health.For show notes and resources, please visit: https://Type2DiabetesTalk.comTo share your questions and suggestions, leave us a voice message or email at: https://Type2DiabetesTalk.com/messageExplore our proven programs and services, visit: https://Type2DiabetesTalk.com/programsSubscribe to our free weekly newsletter for podcast updates, valuable nutrition tips and more: https://Type2DiabetesTalk.com/subscribe
In this Mailbag episode, Dr. Fox answers listener questions covering uterine dehiscence versus uterine rupture, including how they're diagnosed, managed, and what they mean for future pregnancies. He also addresses a listener's recovery and subsequent pregnancy planning after a complete uterine rupture, the effects of maternal sepsis on a fetus, and why many women with gestational diabetes have normal A1C levels outside of pregnancy. As always, Dr. Fox draws on clinical experience and research to give nuanced, reassuring answers to these complex questions.
(A note before we get into it: this article is educational, not medical advice. Talk to your doctor or a registered dietitian before making major changes to your diet — especially if you have diabetes or pre-diabetes, take blood-sugar medication, are pregnant or nursing, or are managing any chronic condition. Nothing here is intended to diagnose, treat, cure, or prevent any disease.)Research shows well-built plant-based diets usually lower blood sugar. If yours moved the other way, one of six silent glucose traps is almost always the reason — and every one of them is fixable.TLDR* The research is actually on vegetarianism's side. Large reviews of clinical trials show vegetarian and vegan diets tend to lower A1C, not raise it.* So if your numbers went up, something in how the diet was built is the real cause — not the fact that it's plant-based.* Six usual suspects: too little protein, “naked” carbs with no brakes, shrinking muscle mass, too much fermentable fiber too fast, high stress/cortisol, and late-night eating.* Each one is a fixable habit, not a reason to abandon vegetarianism.Wait — Doesn't “Plant-Based” Mean Healthier Blood Sugar?Usually, yes. When researchers actually put vegetarian diets to the test in clinical trials, the pattern is consistent: people following them tend to see their A1C go down, not up. A meta-analysis pooling multiple randomized trials found vegetarian diets were linked to a meaningful drop in A1C, and a separate meta-analysis of nine trials found a similar reduction — enough that it would be considered clinically significant by the FDA's own bar for new diabetes drugs.So if you switched to vegetarian eating and your last lab draw came back worse, I want to be straight with you: that's not the expected outcome, and it's not “just what happens” when you cut out meat. Something specific is working against you. The good news is that it's almost always one of a handful of well-understood mechanisms — and once you know which one, it's a quick fix, not a diet overhaul.Think of it like this: a car engine doesn't run worse because you switched to a different brand of gas. It runs worse because something specific — a clogged filter, bad timing, low oil — is getting in the way. Same idea here. Let's go through the six most common “clogs.”THRIVE 120 - TriplePlayDoc is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.1. The Protein Drop You Didn't NoticeThis is the single most common one. When people cut out meat, they usually don't replace that protein gram-for-gram with plant protein — they replace it with more carbs, because carbs are what fill the plate: extra rice, extra bread, extra pasta.Here's why that matters for blood sugar specifically. Protein eaten alongside carbohydrate isn't just “extra food” — it changes how your body handles the carbs. A meta-analysis of controlled feeding trials found that adding protein to a carb-containing meal meaningfully lowers the post-meal glucose spike, largely by boosting the insulin response that clears sugar out of the bloodstream faster. Pull protein out of the meal and carbs hit your blood essentially unguarded.Think of protein as the brakes on a sugar rollercoaster. Take the brakes off, and the same carbs you were eating before now send your blood sugar higher and faster than they used to.2. Naked Carbs, No BrakesThis is the same problem from a different angle: oatmeal for breakfast, a rice bowl for lunch, a smoothie for a snack. All reasonable foods — but if none of them are paired with enough protein or fat, and you're not about to go move that sugar with a workout, it hits your bloodstream as a fast, unbuffered spike. Your body answers with a bigger insulin surge, and doing that meal after meal, day after day, is exactly the pattern linked to declining insulin sensitivity over time.3. The Muscle FactorThis one surprises people: your muscles are the biggest “storage tank” for the sugar you eat. After a meal, skeletal muscle soaks up roughly 70–80% of the glucose that comes out of your bloodstream, using it to refill glycogen stores. Researchers who study this consider muscle glucose uptake the single biggest lever on whole-body insulin sensitivity.So when protein intake drops and resistance training isn't part of the picture, muscle mass tends to shrink over time — and that storage tank gets smaller. Less tank space means the same meal now leaves more sugar circulating in your blood for longer, which shows up as a slow, creeping rise in A1C.Muscle is basically your body's biggest gas tank for sugar. Shrink the tank, and the same fill-up overflows.4. High Fiber, High StressFiber itself is not the villain here — in fact, the right kind of fiber is one of the best tools for blood sugar control. Viscous, soluble fibers (found in oats, beans, and psyllium) form a gel in your gut that physically slows down how fast sugar gets absorbed, and trials show this type of fiber measurably lowers both A1C and fasting blood sugar.The issue is a different kind of fiber problem: volume and speed. Vegetarian diets are often naturally high in fermentable fiber — beans, lentils, certain grains — and when your gut bacteria break that fiber down, the fermentation process produces gas as a byproduct. Ramp up fiber intake quickly, especially the fast-fermenting kinds, and you can outpace your gut's ability to comfortably process it, leading to bloating and discomfort. That physical stress on your body, especially combined with everyday life stress, triggers cortisol release — and cortisol has a direct, well-documented job of raising blood glucose by signaling your liver to make more sugar and by making your cells less responsive to insulin.Think of fiber fermentation like a construction project in your gut. The building itself (your microbiome) benefits — but a project moving too fast kicks up a lot of dust (gas and bloating) along the way.5. Timing and Circadian RhythmsThe lifestyle shift that often comes with going vegetarian — more grazing, more small meals, more snacking — can quietly push more of your eating into the evening. That timing matters more than most people realize. Multiple studies using identical meals given at different times of day have found that the exact same meal produces a bigger blood sugar spike at night than it does in the morning, because your insulin sensitivity and beta-cell function both naturally dip in the evening. One study even found a late meal after 8pm was independently linked to worse A1C.Your body runs on a work shift for carbs. The day shift (morning, early afternoon) handles them efficiently. The night shift is running on a skeleton crew — the same carb load left unprocessed for longer, working against you while you sleep.6. Cortisol: The Common ThreadYou'll notice cortisol keeps coming up — that's not a coincidence. Cortisol's actual job during stress is to make more glucose available fast, by triggering your liver to produce it and by directly blunting how well your cells respond to insulin. Whether the stressor is emotional (a hard week at work) or physical (a gut that's working overtime to ferment more fiber than it's used to, or a body that's lost muscle mass and is struggling to regulate blood sugar as efficiently), the hormonal response is the same: more sugar released, less efficiently cleared.Who's Most Likely to Notice This?Not everyone who goes vegetarian sees their A1C move. The people most likely to notice these effects are those who already have some combination of insulin resistance, chronic stress, poor sleep, low muscle mass, or a sensitive gut. For them, a vegetarian diet doesn't cause the problem — it tends to reveal a metabolic bottleneck that was already there, quietly, underneath a different diet.This isn't a case against vegetarian eating. The clinical research is genuinely favorable toward it. It's a case for building it correctly — with enough protein, the right kind and pace of fiber, resistance training to protect muscle, and carbs eaten earlier in the day, paired with something that slows them down.Six Bottlenecks at a GlanceThe Bottom LineThe question was never really “is vegetarianism good or bad for blood sugar?” — the research says it's generally good when it's built well. The real question is: what's your body's current metabolic bottleneck? Is it protein? Muscle? Fiber pacing? Timing? Stress? Most people are dealing with one or two of these more than the others, and once you know which, the fix is usually a small, specific adjustment — not throwing out the diet.The goal isn't just to tweak what's on your plate. It's to find the actual thing standing between you and the results you were expecting when you made this change in the first place.References* Vegetarian and Vegan Dietary Patterns to Treat Adult Type 2 Diabetes: A Systematic Review and Meta-Analysis of RCTs — ScienceDirect: https://www.sciencedirect.com/science/article/pii/S2161831324001285* Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis — PubMed: https://pubmed.ncbi.nlm.nih.gov/25414824/* The Effect of Adding Protein to a Carbohydrate Meal on Postprandial Glucose and Insulin Responses: A Systematic Review and Meta-Analysis — ScienceDirect: https://www.sciencedirect.com/science/article/pii/S0022316624003924* The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise — Frontiers in Physiology: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2011.00112/full* Glucose Uptake by Skeletal Muscle within the Contexts of Type 2 Diabetes and Exercise — MDPI/Nutrients: https://www.mdpi.com/2072-6643/14/3/647* Effect of viscous soluble dietary fiber on glucose and lipid metabolism in patients with T2DM: systematic review and meta-analysis — PMC: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500602/* Dietary fiber in irritable bowel syndrome (fermentation and gas production) — PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC5548066/* Fibre, fermentation, FODMAPs and flatulence — Quadram Institute: https://quadram.ac.uk/blogs/fibre-fermentation-fodmaps-and-flatulence/* Physiology, Cortisol — StatPearls, NCBI Bookshelf: https://www.ncbi.nlm.nih.gov/books/NBK538239/* Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans — PNAS: https://www.pnas.org/doi/10.1073/pnas.1418955112* Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes — Diabetologia/PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC7002226/* Chronotype, Chrononutrition and Glucose Tolerance Among Prediabetic Individuals (late-dinner/A1C link): https://cdn.clinicaltrials.gov/large-docs/64/NCT05163964/Prot_SAP_ICF_004.pdfTHRIVE 120 - TriplePlayDoc is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit tripleplaydoc.substack.com/subscribe
Episode 308This week is a solo Front Porch session filled with personal updates, World Cup excitement, creative projects, and another trip into the Dungeon.❤️ Front Porch Check-In Five years after being diagnosed with Type 2 Diabetes, I share the latest from my doctor's appointment, my updated A1C, what's working, what still challenges me, and the habits that have helped me along the way.
We follow the footnotes on a common gyn rule, then use that same evidence-first lens to question popular fertility add-ons and persistent pregnancy myths. Along the way, we talk pretest probability, counseling tradeoffs, and why simple cutoffs often replace better clinical reasoning. • tracing the “biopsy Bartholin cysts after 40” claim back to weak citations • using pretest probability and exam features to decide on selective biopsy • weighing hysteropexy versus hysterectomy for prolapse with long-term cancer risk in mind • breaking down a Lancet review of IVF add-ons and what actually shows benefit • spotting how marketing and online forums amplify unproven fertility interventions • reviewing data on sedentary time in pregnancy and why activity restriction persists • debunking “walking progresses labor” with randomized trial evidence • clarifying early diabetes testing as screening for preexisting diabetes and when A1C makes more sense than early glucose tolerance tests Be sure to check out thinkingaboutobgyn.com for more information and be sure to follow us on Instagram.0:00 Welcome And What's Ahead0:23 Bartholin Cyst Biopsy Age Rule14:17 Prolapse Repair With Uterus Preservation21:45 IVF Add-Ons And The Lancet Review37:35 Pregnancy Activity Myths And New Data50:53 Early Diabetes Testing And A1CFollow us on Instagram @thinkingaboutobgyn.
Chimezie is performing an initial examination of a patient with type 2 diabetes mellitus. The patient's most recent hemoglobin A1C is 6.7%. During inspection of the right foot, the therapist observes a small ulcer on the plantar surface beneath the fifth metatarsal head. The patient reports progressively limiting walking activities because of discomfort in the involved foot. Which of the following examination procedures is MOST important for the therapist to perform?A) Measure the patient's maximum ambulation distanceB) Inspect the medial ankle for additional ulcerationC) Test protective sensation using a 10-g monofilamentD) Measure capillary blood glucose before continuing the examinationText our team the word COACH for a free diagnostic: (727) 732-4573
Chris Roome was diagnosed with Type 1 diabetes at 12 after waking up in the ICU, but for years, managing his T1D wasn't his priority. Through his teens and early adulthood, he struggled with teenage rebellion, addiction, an A1C of 12, and eventually reached a turning point that changed the course of his life.. Within a year of getting sober, his A1C dropped to under 6.Today, Chris has completed multiple marathons, 50+ mile ultramarathons, and founded Project InsulNation, an organization leading backcountry expeditions exclusively for adults living with Type 1 diabetes.In this episode, Chris sits down with Lauren to share how recovery transformed the way he approached T1D, the exact insulin and fueling strategies he uses during ultra-endurance races, the moment his pump site ripped out halfway through a 50-mile trail run, and why he's on a mission to help more adults with Type 1 diabetes discover they're capable of far more than they've been led to believeWHAT WE COVER:What it was like waking up in an ICU at 12, going months without checking his blood sugar, and what finally forced everything to changeThe direct connection between getting sober and getting his A1C from a 12 to under 6 in one yearThe exact fueling and insulin strategy he uses to run 50-plus miles without his blood sugar crashingWhat happened when his insulin pump ripped out in the middle of a race, and how he still crossed the finish lineWhy endurance sports gave him a completely different perspective on living with Type 1 diabetesThe inspiration behind Project InsulNation and why he's creating outdoor expeditions specifically for adults with T1DWhat it looks like to join a Project InsulNation expedition, and who it's forWHAT'S NEXT:
In this first episode of the Know Your Numbers series, I discuss why understanding your basic health numbers can help you make informed decisions before serious health problems develop. The focus of this episode is blood glucose (blood sugar)—what it measures, why it matters, and practical steps you can take to maintain healthy levels.In This Episode:•Why knowing your health numbers is an important part of preventive care.•Why we shouldn't accept unhealthy numbers as "normal" simply because of age, race, or family history.•The difference between a fasting blood glucose test and an A1C test, and why both are valuable.•Healthy fasting blood glucose ranges and what elevated numbers may indicate.•How excess blood sugar can damage blood vessels, nerves, kidneys, eyes, and other organs over time.•Understanding insulin resistance and its role in Pre-diabetes and Type 2 diabetes.Common symptoms of elevated blood sugar, including:Frequent urinationExcessive thirstFatigueVision changesSweet-smelling breathWhy people with diabetes should pay close attention to foot health and circulation.Simple lifestyle changes that can help improve blood sugar levels:•Eat more whole, fiber-rich foods.•Reduce ultra-processed foods and sugary beverages.•Read food labels carefully and recognize hidden sugars.•Choose whole fruit instead of fruit juice.•Move your body after meals—even a short walk can make a difference.Coming Up Next:This Know Your Numbers series will continue with discussions on blood pressure, cholesterol, body weight and other important health markers we should understand.If you found this episode helpful, please subscribe, leave a review, and share it with someone who could benefit from learning more about their health.Please subscribe to Nurah Speaks on YouTube and follow the podcast on your favorite streaming platform. Be sure to like, share and leave a comment. I would love to hear your thoughts on this conversation.You can follow Nurah Speaks on X, Instagram and Facebook @NurahSpeaks.
Let's talk about the five biggest drivers of blood sugar and how improving them can help support your energy, reduce cravings, improve insulin resistance, lower your fasting glucose and hemoglobin A1c, support weight loss, and improve your long-term metabolic health.Access the Mindful Eating & Healthy Living Course here:https://yourlifenutrition.org/course/ Schedule a FREE Discovery Call with me here:https://yourlifenutrition.org/nutrition-coaching-application/.Come join our private accountability group, the Goal Getters Group, for all things health, wellness & nutrition! You'll get sample weekly meal plans, recipes, weekly group coaching calls and access to our exclusive Blood Sugar, Wellness, Mindfulness & Movement Challenges to help support you and keep you accountable on your health & nutrition journey AND get access to private messaging with me, your dietitian!Click the link below to join the Goal Getters Group today!https://your-life-nutrition-goal-getters.mn.co/plans/1821314?bundle_token=1724009ab3ed355237fdeeebd2fe1d9f&utm_source=manual.For health & nutrition tips, recipes & more - follow me on:Instagram: https://www.instagram.com/yourlifenutrition/Facebook: https://www.facebook.com/yourlifenutritionrdn/Email: Brittany@yourlifenutrition.orgShop my Favorite Products!Stelo Continuous Glucose Monitor System**I am an Amazon Affiliate and may earn commissions on qualifying purchases.
I loved this conversation with Dr. Aimee, also known as the Egg Whisperer. She's so real, honest, authentic and dedicated. In our conversation she shares practical insights, innovative treatments, and inspiring stories to empower women on their fertility journeys. Whether you're just starting or deep into treatment, this episode offers invaluable advice for building your family. We cover: The importance of activity and lifestyle habits for fertility Debunking myths around fertility treatments and advice Essential lab markers everyone should know The role of innovative therapies like rapamycin and ovarian PRP Navigating emotionally supportive care and self-advocacy in fertility Future technologies that could revolutionize reproductive health In this episode: Dr. Aimee emphasizes the significance of staying active for fertility, explaining how movement influences inflammation and metabolism She shares her stance on common misconceptions, including the debunking of semen ingestion and the necessity of sex before embryo transfer The discussion highlights the critical lab markers: hemoglobin A1c, iron studies, AMH, FSH, and ultrasounds for ovarian reserve Explore cutting-edge approaches like rapamycin and ovarian PRP to extend fertility potential, including success stories of women over 40 Insights into supporting patients emotionally, delivering bad news with compassion, and advocating for oneself across the fertility journey A glimpse into the future: potential of in vitro gametogenesis (IVG), fertility regeneration, and the quest to extend reproductive longevity Timestamps: 00:00 - Introduction and importance of trusted fertility resources 02:05 - The impact of activity and movement on fertility health 01:36 - Myths and overrated fertility advice, including semen swallowing and sex timing 02:38 - Coffee's role in fertility, debunking misconceptions 02:45 - Essential lab markers: Hemoglobin A1c and iron studies 03:21 - Recommended screenings: AMH levels and fertility preservation discussions 04:23 - Women over 40 and natural vs. assisted pregnancy possibilities 05:42 - Critical fertility tests: AMH, FSH, and ovarian reserve 06:44 - Simplifying AMH and FSH: what do these markers really mean? 08:17 - Egg quality assessments and genetic testing limitations 09:19 - Handling retrievals with low follicle counts and the future of single-egg IVF 10:29 - Dr. Aimee's motivation for supportive fertility care over clinic statistics 11:29 - Trends towards IVF with fewer eggs and clinic evolution 12:03 - The journey of the Egg Whisperer and family influences 14:07 - Supporting emotional well-being through compassion, mental health referrals, and personal connection 16:23 - Building a holistic team for fertility success 18:05 - Self-advocacy: knowing your medical records and asking the right questions 20:24 - Expected attrition rates in IVF success and understanding the 'pyramid' 22:37 - Lifestyle, supplements, and experimental therapies for improving outcomes 23:39 - Innovations: rapamycin and ovarian PRP, their potentials and success stories 28:35 - Historical FDA use of rapamycin and current fertility applications 29:39 - The procedure and promise of ovarian PRP 35:16 - The need for more gender-specific women's health research 41:10 - Emerging future technologies, including IVG and fertility regeneration 43:09 - Tips for those beginning their fertility journey and critical questions to ask 44:44 - What does living well mean? Personal insights from Dr. Aimee Resources & Links: Dr. Aimee - The Egg Whisperer Rapamycin case series publication Ovarian PRP details Anti-aging and longevity insights Fertility Tools & Supplements Connect with Dr. Aimee: Instagram Twitter Website Connect with me: Connect with me on Instagram ShopMy - What I'm Loving Lately Email: Hailey@hailey-miller.com
Barbara Court is almost 75 years old, full of humor, full of heart, and living proof that it is never too late to get Plant Strong.After joining PlantStrong's free Real30 Challenge, Barbara committed to eating 30 different whole plant-based foods each week and moving her body for 30 minutes a day. In just a few months, she lost nearly 15 pounds, brought her A1C out of the pre-diabetic range, increased her daily steps, and found a renewed sense of motivation.In this conversation, Rip and Barbara talk about weight loss, calorie density, plant diversity, arthritis, movement, simple meals, social temptations, community support, and why perseverance and humor matters more than perfection.Barbara's message is simple and powerful: you do not have to be perfect. You just have to keep going.In this episode:How Barbara found success with the Real30 ChallengeWhy she tracks her weekly plant diversityHow she lost nearly 15 poundsWhat helped her improve her A1CWhy calorie density finally clickedHow she handles tempting foods and social eventsWhy daily movement is non-negotiableThe power of online community and encouragementWhy it is never too late to change your healthWatch on YouTubeLearn More About our 2026 Live PLANTSTRONG Events: https://plantstrongevents.com/ Let Us Help Your PLANTSTRONG JourneyLearn More About Our Corporate Wellness Program: https://liveplantstrong.com/corporate-wellness/ COMPLEMENT: Use code PLANTSTRONG for 30% off at https://lovecomplement.com/pages/plantstrong-special-offer Follow PLANTSTRONG and Rip Esselstynhttps://plantstrong.com/ https://www.facebook.com/GoPlantstrong https://www.instagram.com/goplantstrong/https://www.instagram.com/ripesselstyn/ Follow the PLANTSTRONG Podcast and Give the Show a 5-star RatingApple PodcastsSpotify
Are your blood markers telling you and your doctor the whole story? Chronic inflammation is the silent driver behind nearly every major disease, and the good news is that your lifestyle choices decide the outcome. Don't wait for a life altering diagnosis to take action.In this episode of Salad With a Side of Fries, host Jenn Trepeck breaks down how blood markers move, how preventable diseases develop, and why epigenetics means your genes are not your fate. If you have ever felt like your health was out of your hands, this episode will change the way you think about your daily choices.What You Will Learn in This Episode:✅ Why chronic inflammation is considered the root cause of virtually every major illness and how oxidative stress accelerates disease progression in the body.✅ How epigenetics reveals that your lifestyle choices, not just your genetics, impact disease-related genes.✅ What specific blood markers to track for heart disease, type 2 diabetes, liver disease, and kidney disease, and realistic timelines for improving them.✅ How to advocate for yourself in a medical system still rooted in a prescription-first approach, and how to ask your doctor for the time and space to make disease prevention changes first.The Salad With a Side of Fries podcast, hosted by Jenn Trepeck, explores real-life wellness and weight-loss topics, debunking myths, misinformation, and flawed science surrounding nutrition and the food industry. Let's dive into real-life wellness and weight loss, including drinking, eating out, and skipping the grocery store.TIMESTAMPS:00:00 Preventable diseases don't have to be your story and what blood markers can and cannot tell you05:55 The most common diseases: heart disease, type 2 diabetes, and cancer and how they are linked to lifestyle choices06:46 Epigenetics explained: how your daily habits turn disease risk genes up or down17:21 Lifestyle choices, from gut health to the brain to the endocrine system, impact every organ system20:10 Oxidative stress and free radicals explained: the science behind chronic disease25:01 Lifestyle choices that support overall health rather than disease and healthcare 3.0, being your own advocate32:12 Discussion of food with no labels; vegetables, fruit and lean meat36:19 Movement as disease prevention: why sitting all day quietly drives chronic illness more than we realize41:06 Longevity, community, connection, sleep, and stress management as overlooked pillars of health42:05 Blood marker timelines: how fast insulin, A1C, cholesterol, and blood pressure respond to lifestyle changesKEY TAKEAWAYS:
Too busy to read the Lens? Listen to our weekly summary here! In this week's episode we discuss:Ocular inflammation, (along with female sex and treatment interruptions) were significant risk factors for developing anti-adalimumab antibodies, which happened in approximately 1/5th of patients on treatment with Adalimumab.Thinning of the ganglion cell layer/inner plexiform layer and outer retinal layers in children with type 1 diabetes was associated with higher A1c values.A review of methicillin-resistant staphylococcus aureus keratitis showed high levels of multidrug resistance, but all were susceptible to vancomycin. On average, there was no improvement in vision after treatment and a high number required procedural or surgical intervention.
It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Transcript & links: Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/ XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy. In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings. Following is a transcript of his remarks: What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses. Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity]. And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%. However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment. Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment. Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure. And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin. So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment. So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance. Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care. Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing. The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season. https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/
Attend a Live Q&A with Dr. Glandt. Reigster here.What if the way we treat type 2 diabetes is fundamentally backwards?Dr. Mariela Glandt is an endocrinologist and obesity medicine specialist who spent 15 years practicing conventional medicine before concluding, in her words, that how we treat diabetes “is actually upside down.” As co-founder of OwnaHealth, she focuses on addressing the insulin resistance underlying type 2 diabetes, not only the elevated blood sugar it eventually causes.In this episode, she walks through the science of that shift: why fasting insulin may reveal metabolic dysfunction before A1C becomes abnormal, why a laboratory “normal” range running up to 20 can be misleading, and why she believes repeatedly escalating insulin can contribute to weight gain, reduced insulin responsiveness, and worsening metabolic health.She also shares what she has learned bringing low-carbohydrate and ketogenic therapy to underserved communities in the South Bronx, where patients may be navigating severe diabetes alongside financial pressure, cultural food traditions, psychiatric illness, chronic stress, and conflicting medical advice. Her work shows that these therapies can succeed even in communities facing significant barriers to care.Dr. Glandt also breaks down what GLP-1 medications actually do, where they can help, and what they may leave unresolved—including the risks of muscle loss, inadequate protein intake, and relying on medication without addressing the patient's broader metabolic health.Questions Answered in This Episode:• What key mindset shifts do conventionally trained physicians need to make when transitioning to a more integrated approach to medicine?• How does reframing diabetes as insulin resistance change the way a doctor practices?• What are the earliest signs of metabolic dysfunction that many clinicians miss?• Can ketogenic metabolic therapy succeed in underserved communities?• What do GLP-1 medications actually solve, and what do they leave untouched?• Where can ketogenic therapy and GLP-1 medications work together?• What has Dr. Glandt observed in patients living with both metabolic and psychiatric illness?• Where does endocrinology most need to change course?Viewers will come away with a different lens on metabolic disease, one that looks beyond glucose and weight to the biological, social, and practical factors shaping a patient's health.More links:For Richer, for Poorer: Low-Carb Diets Work for All IncomesOwnaHealth: Reverse the course of chronic disease — for everyone.Special thanks to the sponsors of this episode:✅ Toups and Co – Get 15% off your first order with code METABOLIC here.✅ iRestore – Get a huge discount on the Elite and the Illumina bundle with the code LINK here.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: InstagramFacebookYouTubeLinkedInPlease keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.
If your doctor has ever told you, "Your labs look normal," while you're struggling with exhaustion, brain fog, weight gain, anxiety, poor sleep, or hot flashes, this episode is for you.Millions of women navigating perimenopause and menopause are told their symptoms are simply part of aging. But what if there was more to the story?In this podcast, we sit down with Jackie Roberts, a midlife health educator with more than 30 years of experience in laboratory medicine and the pharmaceutical industry, to uncover why so many women feel unheard, misunderstood, and left searching for answers during the menopause transition.Together, we explore why hormone symptoms are often treated one at a time instead of looking at the bigger picture. Jackie explains how the Women's Health Initiative (WHI) changed the conversation around hormone replacement therapy (HRT), what we've learned since that landmark study, and the important differences between synthetic hormones and bioidentical progesterone. Most importantly, she shares how women can have informed, personalized conversations with their healthcare providers instead of accepting, "You're just getting older," as the final answer.We also take a practical deep dive into menopause hormone testing and discuss:• The hormone labs that may help tell the bigger story, including FSH, LH, estradiol, progesterone, and testosterone • Why timing your lab work during your cycle can make a significant difference • Additional labs that may help rule out other conditions, including thyroid function, iron, ferritin, prolactin, A1C, and glucose • How chronic stress, cortisol, inflammation, and body composition affect your health after 40 • Why strength training, adequate protein, and lifestyle habits become increasingly important during midlife • The powerful role that community, emotional support, and spiritual wellness play in thriving—not just surviving—through menopauseWhether you're in perimenopause, menopause, or postmenopause, this conversation will leave you with practical questions to ask, greater confidence when talking with your healthcare provider, and a deeper understanding of what your body may be trying to tell you.If you're ready to stop guessing and start advocating for your health, press play today.If you enjoyed this episode, please subscribe, leave a review, and share it with a woman who deserves to know she's not imagining her symptoms—and she's certainly not alone.BioI bridge the gap between science and spirit in menopause care. With 30+ years in Laboratory Medicine and pharmaceuticals, including Hormone Replacement Therapy, and a background in award-winning coaching leadership, I help women stop fighting their bodies and start working with them. After navigating my own menopause challenges, I now guide women to restore strength, clarity, and connection—physically, mentally, and spiritually.Social Media InstagramFacebookSubstackYouTubeWebsiteMenopause Strength ResetPlease Patronize Our Sponsors Healthy aging starts from the inside out. Great Lakes Wellness Collagen is made with clean, grass-fed collagen peptides that are iGen Non-GMO tested, dissolve effortlessly in hot or cold liquids, and fit seamlessly into your daily routine. I personally use it to support healthy skin, stronger hair, joint comfort, and gut health. If you're looking for a simple way to nourish your body after 40, this is one of my favorite daily wellness essentials.Learn more by clicking here. Special Discount Code: VIBEWELLNESSWOMANIf you're curious about supporting your metabolism naturally, check out Ora Organic's GLP-1 Up. It's a plant-based supplement formulated with four clinically studied botanical ingredients that help support your body's natural GLP-1 production, healthy blood sugar response, appetite regulation, and energy balance.CLICK HERE FOR MORE INFORMATIONIf you are ready to try natural HRT check out VITAFEM - A doctor-formulated menopause supplement built for all 5 hormones. CLICK HERE FOR MORE INFORMATION
Therapist Erika Forsyth on the emotional weight of diabetes: trusting your settings, hypervigilance and cortisol, the pre-bolus wait, identity and grief, and the self-compassion shown to lower stress and A1C. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi ABLEnow save for today's needs or invest for tomorrow Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 20% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Brown et al. Diabetes Care (2021). Sherr et al. Diabetes Care (2022). Pasquel FJ, et al. JAMA Network Open (2025). Single-arm studies comparing 3 months of Omnipod 5 use to standard therapy in 240 people aged 6-70 years and 80 people aged 2-5.9 years with type 1 diabetes and 305 people aged 18-75 years with type 2 diabetes. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Join our Hernia Team for a review of the current controversy around preoperative optimization and the practical implications.Hosts: Dr. Maggie Bosley - @MBosleyMD Dr. Sean Orenstein - @OrensteinSean Dr. Amber Sandoval Dr. Peter Ferrin Institution: Oregon Health & Science UniversityReferences:Adverse Events after Ventral Hernia Repair: The Vicious Cycle of Complicationshttps://pubmed.ncbi.nlm.nih.gov/26206646/Risk factors for postoperative wound infections and prolonged hospitalization after ventral/incisional hernia repairhttps://pubmed.ncbi.nlm.nih.gov/24030572/lack of association between glycated hemoglobin and adverse outcomes in diabetic patients undergoing ventral hernia repair: an ACHQC studyhttps://pubmed.ncbi.nlm.nih.gov/35969297/Impact of preoperative haemoglobin A1c levels on postoperative outcomes in adults undergoing major noncardiac surgery: A systematic reviewhttps://pubmed.ncbi.nlm.nih.gov/38853752/Does active smoking really matter before ventral hernia repair? An AHSQC analysishttps://pubmed.ncbi.nlm.nih.gov/30220485/Abstinence from smoking reduces incisional wound infection: a randomized controlled trialhttps://pubmed.ncbi.nlm.nih.gov/12832959/The Association of Nicotine Replacement Therapy With Outcomes Among Smokers Hospitalized for a Major Surgical Procedurehttps://pubmed.ncbi.nlm.nih.gov/31790653/Is weight trajectory a better marker of wound complication risk than BMI in hernia patients with obesity?https://pubmed.ncbi.nlm.nih.gov/38082008/Gender, racial, and socioeconomic disparity of preoperative optimization goals in ventral hernia repairhttps://pubmed.ncbi.nlm.nih.gov/37658198/Limited or Lasting: Is Preoperative Weight Loss as Part of Prehabilitation Maintained after Open Ventral Hernia Repair?https://pubmed.ncbi.nlm.nih.gov/39907236/The impact of preoperative optimization for abdominal wall reconstruction on long-term glucose control and smoking cessationhttps://pubmed.ncbi.nlm.nih.gov/40739418/Watchful waiting as a treatment strategy for patients with a ventral hernia appears to be safehttps://pubmed.ncbi.nlm.nih.gov/26838293/Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US
What if your diagnosis wasn't the beginning of the end — but the beginning of everything? Eight years ago, Bettina Gordon-Wayne was handed a breast cancer diagnosis on a beautiful spring day in Washington, D.C. She had a four-year-old at home, a healthy lifestyle, and zero warning signs. Today, she is eight years cancer-free and biologically 12 years younger than her chronological age. And she has the data to prove it. Bettina spent 30 years as an international journalist interviewing world leaders, billionaires, and global experts. She was always the one asking the questions — until life gave her a story she couldn't cover from a distance. So she turned her investigative rigor toward the science of longevity, logged thousands of hours of research, and rebuilt her health from the inside out. Her TEDx talk "Aging Well, Aging in Reverse" surpassed 100,000 views. Her book The Joy of Later Motherhood sparked a global conversation. And her program, Younger With Age, is helping high-achieving midlife women do exactly what she did — reverse their biological age with data that proves it. In this episode, Dr. Anna and Bettina cover: Why biological age matters far more than the candles on your birthday cake How Bettina conceived naturally at 43 after a year of failed attempts — and what changed The mindset shift that separates women who age slowly from women who don't Why healthy living didn't prevent cancer — and how it saved her life anyway The unsexy, free anti-aging strategy that outperforms every biohack How to become a "beauty hunter" and lower cortisol through intentional joy The two words to say to anyone who tells you your best years are behind you Memorable Quotes: We can have true agency over the way we age. — Bettina Gordon-Wayne We can truly get younger with age.— Bettina Gordon-Wayne Get out of the victimhood and become defiant.— Bettina Gordon-Wayne The goal is not just to get older. The goal is to create a life that you are excited to live. — Bettina Gordon-Wayne If anybody tells you that you're too old, too gray, that your ship has sailed, look them straight in the eye and tell them two words: Watch me.— Bettina Gordon-Wayne "Our body is the cathedral of our spirit." — Dr. Anna Cabeca "For every day God gives us, let it be as healthy, vital, and purposeful as possible." — Dr. Anna Cabeca "Health shows vitality." — Dr. Anna Cabeca "Your diagnosis is not your destiny." — Dr. Anna Cabeca "Your diagnosis is not your destiny." — Dr. Anna Cabeca "Our body is the best pharmacy in the world." — Dr. Anna Cabeca Take Bettina's free biological age quiz at bettinagordon.com/quiz and learn more about the Younger With Age program at bettinagordon.com/program. Key Timestamps: 00:00 — Dr. Anna opens: "Our body is the cathedral of our spirit" — why renovation and repair are the foundation of longevity 02:15 — Introducing Bettina: from international journalist to first-time mom at 44 to breast cancer survivor to 12 years biologically younger 04:00 — Can we actually reverse biological age in our 50s and 60s? Bettina's answer is a clear yes 06:30 — Bettina's journey to later motherhood: why she didn't want children, what shifted at 43, and conceiving naturally after a year of failed attempts at 40 12:00 — Chronological age vs. biological age: what the difference actually means, the Horvath clock, and why biological age is the only number that matters 16:45 — "I don't do cancer, I do health" — the moment Bettina's world stopped on a spring day in D.C. 20:00 — Why a healthy lifestyle didn't prevent the diagnosis — and why her oncologist said it saved her life anyway 24:30 — The epigenetics of breast cancer: how choices made in your 30s show up as disease in your 40s and 50s 27:00 — "Get out of the victimhood and become defiant" — the mindset non-negotiable for aging on your own terms 31:00 — The racehorse framework: is this racehorse food or mule food? A reframe that makes healthy choices feel like self-respect, not deprivation 36:00 — The unsexy truth: sleep, movement with joy, stress reduction, and community are the top anti-aging strategies — and they're free 40:00 — "Become a beauty hunter" — Bettina's favorite daily practice for regulating the nervous system and activating the parasympathetic state 44:00 — Lab markers worth tracking: hemoglobin A1C, hsCRP, fatty acid ratios, vitamin D, and the biological age testing companies worth knowing 49:00 — Loving a body full of scars: what Bettina sees in the mirror at 56 and why it has nothing to do with how it looks 53:00 — "Watch me" — Bettina's closing message to every woman who has been told she's too old, too gray, or that her ship has sailed Connect with Bettina: LinkedIn: linkedin.com/in/bettinagordon TikTok: @bettina.gordon TEDx Talk: Aging Well, Aging in Reverse Connect with Dr. Anna: Website: Dranna.com Instagram: @thegirlfrienddoctor YouTube: @thegirlfrienddoctor TikTok: @drannacabeca Facebook: thegirlfrienddoctor
In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including: Importance of moving beyond a glucose-centric approach to T2D care Current evidence for incretin-based therapies in T2D Rationale for integrating these therapies into the primary care setting Shared decision-making strategies to discuss optimal T2D treatment options with patients Timing for endocrinology referral Presenters: Jennifer Green, MD Professor of Medicine Division of Endocrinology Duke Clinical Research Institute Duke University School of Medicine Durham, North Carolina Jay H. Shubrook, DO, FAAFP, FACOFP Professor, Diabetologist Department of Clinical Sciences and Community Medicine Touro University California, College of Osteopathic Medicine Vallejo, California Full program link: https://bit.ly/4uSKCqv Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Have you ever stepped off the bodybuilding stage and felt like your body went off the rails? You did not ruin your metabolism—your post-show plan did! In this must-listen episode, IFBB Olympian & NASM Master Trainer Andre Adams breaks down exactly how to repair post-show insulin sensitivity, regain hormonal balance, and set yourself up for a successful off-season. What You'll Learn: · The real reason most competitors rebound after a show (hint: it's not just “cheat meals”) · Proven nutrition strategies to boost insulin sensitivity and metabolism · Why controlled reverse dieting is critical—and common mistakes to avoid · How to monitor key blood markers (fasting glucose, HOMA-IR, A1c) and HTMA mineral ratios · Powerful supplements and peptides (including berberine, GDA, MOTs-C, and more) for faster recovery · Step-by-step training adjustments for rapid rebound control (cardio tapering, deloads, periodization) · Avoiding the binge/yo-yo cycle—why structure is freedom · Insider tips for maximizing lean growth while minimizing fat gain in your off-season Who Should Watch? · Bodybuilding athletes (natural or enhanced) · Physique competitors & fitness models · Coaches and trainers seeking advanced post-show protocols · Anyone struggling with post-diet rebounds or metabolic slowdowns If you like what you just consumed, leave us a 5-star review, and share this episode with a friend to help grow our NASM health and wellness community! The content shared in this podcast is solely for educational and entertainment purposes. It is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek out the guidance of your healthcare provider or other qualified professional. Any opinions expressed by guests and hosts are their own and do not necessarily reflect the views of NASM. Introducing NASM One, the membership for trainers and coaches. For just $35/mo., get unlimited access to over 300 continuing education courses, 50% off additional certifications and specializations, EDGE Trainer Pro all-in-one coaching app to grow your business, unlimited exam attempts and select waived fees. Stay on top of your game and ahead of the curve as a fitness professional with NASM One. Click here to learn more. https://bit.ly/4ddsgrm
Imagine being penalized for delivering good care to your frailest patients. Medicare's quality scoring program was built for healthy outpatients, not the elderly residents of nursing homes, but it is the system doctors who round in skilled nursing facilities are forced to play. Steve Buslovich, a physician executive and geriatrician, discusses the KevinMD article "How Medicare's MIPS impacts skilled nursing facilities and clinicians." You'll hear how MIPS metrics conflict with the five-star quality measures facilities must report, why tightly controlling A1C in frail elders can cause harm, and how documentation discrepancies between physicians and facilities create financial and legal risk for both. You'll learn which nine measures actually fit post-acute long-term care, why CMS needs frailty-based quality metrics, and how AI and synced EHRs can pull data automatically so clinicians can get back to the bedside. If you practice in or operate a nursing home, this conversation names the rules of a game you didn't choose to play. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended
Is type 2 diabetes an incurable, progressive disease, as many doctors claim? The research says no. There is a simple, food-based approach that has been quietly studied since the 1970s, and it has helped people get their A1C back to normal without Metformin, without insulin, and without giving up a social life. In this episode, Chris Reade, entrepreneur and author of Beating Diabetes, shares his own story: his A1C jumped from normal to 9.1 in a single year, his doctor handed him a prescription and told him diabetes was an incurable, progressive disease. He walked out of that office and decided to find another way. Four months later, his A1C was back in the normal range. No Metformin. No insulin. No extreme diet. Listen now and start taking control of your blood sugar today! For show notes, visit https://fivejourneys.com/podcasts/soluble-fiber-may-be-your-best-tool-to-reverse-type-2-diabetes/ Follow us on Instagram at https://www.instagram.com/feelfreakingamazing/ Related Episodes Reverse Pre-Diabetes with a Fasting-Mimicking Diet, with Dr. Joseph Antoun How to Stop Taking Metformin, Insulin, and Ozempic for Good, with Dr. Jeffrey Hockings Lose Weight By Improving Your Leptin Sensitivity, with Dr. Bindiya Gandhi Lower Your Risk for Cancer & Chronic Diseases, with Dr. Greg Eckel Reverse Chronic Diseases using Allulose, with Neil Gyte Overcome 14 Chronic Illnesses, with Ashok Gupta Lose Weight By Getting Healthy, with Ben Azadi Try Keto for Optimal Health, with Robert & Crystal Sikes Leverage Ketosis and Fasting to Reverse Disease, with Ben Azadi Unlocking Longevity: Transform Your Health with a Fasting Mimicking Diet, with Dr. Joseph Antoun Why 16 Hours Isn't Enough for True Fasting Benefits, with Dr. Chris Rhodes Why Eating While Fasting Could Give You Better Results, with Renee Fitton
Show Notes HOST Melody Hartzler | | Book Appointment AROUND THE TABLE Mariya Farooqi | Book Appointment AROUND THE TABLE Diane Brice | | Book Appoinment In Today's Episode What happens when healthcare providers become patients themselves? In this candid conversation, PharmToTable pharmacists Dr. Mariya and Dr. Diane share the personal health challenges that led them into functional and integrative medicine—from insulin resistance and metabolic dysfunction to autoimmune disease and postpartum health struggles. Their stories reveal the power of looking beyond symptoms, addressing root causes, and becoming your own health advocate. Key Take Aways Personal health challenges often spark the journey into functional medicine, as both Mariya and Diane discovered through their experiences with unexplained symptoms, weight gain, metabolic changes, and autoimmune disease. Insulin resistance is a foundational driver of chronic disease, with blood sugar dysregulation contributing to weight gain, inflammation, autoimmune conditions, cardiovascular disease, and accelerated aging. Healing requires more than symptom management; while medications have an important place in healthcare, lasting improvement often comes from addressing root causes such as nutrition, stress, sleep, gut health, and lifestyle habits. Functional medicine is a journey, not a quick fix, and meaningful health improvements often require consistency, patience, and sustainable lifestyle changes over time. Patients must become active participants in their care by advocating for themselves, asking questions, tracking progress, and partnering with knowledgeable healthcare providers to improve long-term health outcomes.outcomes. Topics Discussed 00:00 – Welcome to Table Talk Melody introduces PharmToTable, the functional medicine team, and the power of sharing personal health stories. 01:28 – Meet Dr. Mariya Mariya shares her background as a pharmacist, nutrition professional, and educator working in lifestyle and functional medicine. 02:29 – Meet Dr. Diane Diane discusses her pharmacy career, medication therapy management experience, and transition toward prevention-focused care. 04:42 – Why Functional Medicine Requires Time The team discusses the limitations of conventional healthcare visits and the importance of deep, individualized patient care. 05:02 – Mariya's Personal Health Journey Navigating motherhood, stress, weight gain, rising A1C levels, and the realization that self-care required more than surface-level solutions. 06:24 – The Continuous Glucose Monitor Wake-Up Call How CGM data revealed hidden blood sugar spikes and transformed Mariya's understanding of nutrition and metabolic health. 08:03 – Why CGMs Can Be Powerful Learning Tools The team discusses how real-time glucose data can motivate meaningful lifestyle changes. 10:00 – Insulin Resistance as a Root Cause Exploring the connection between blood sugar regulation, inflammation, chronic disease, cancer risk, and longevity. 11:10 – Diane's Autoimmune Story Begins A postpartum diagnosis of psoriatic arthritis leads Diane on a search for answers beyond conventional treatment. 13:17 – Receiving a Life-Changing Diagnosis The emotional impact of being told she would need medication for the rest of her life. 14:22 – Discovering Functional and Naturopathic Medicine How acupuncture, nutrition, supplements, elimination diets, and lifestyle changes helped Diane reclaim her health. 16:48 – From Personal Healing to Professional Passion Why Diane became passionate about helping others address chronic disease through lifestyle medicine. 17:14 – The Importance of Self-Advocacy The team discusses navigating the healthcare system and taking ownership of personal health decisions. 18:26 – Why Healing Takes Time Understanding realistic expectations, root-cause healing, and the patience required for lasting change. 20:41 – Tracking Progress Objectively How symptom questionnaires and health metrics help patients recognize improvements they might otherwise overlook. 21:50 – The Role of Family Support Diane shares how support systems can influence long-term health success. 23:00 – Autoimmune Conditions, Food Sensitivities & Gut Health A patient case study illustrates why addressing gut health is critical for long-term autoimmune management. 25:10 – Functional Medicine and Pharmaceuticals Can Coexist The team discusses balancing natural approaches with appropriate medical interventions when necessary. 26:00 – When Medication Is the Right Tool Examples involving ulcerative colitis, eczema, and severe symptoms that require immediate treatment before root-cause work can begin. 28:36 – Conversations Around Statins and Prevention Exploring medication hesitancy, cardiovascular risk, and the importance of individualized decision-making. 30:39 – Mental Health, Medications, and Removing Stigma Why some patients benefit from short-term pharmaceutical support while building sustainable lifestyle foundations. 32:05 – Questions Every Patient Should Ask How to advocate for yourself by discussing treatment goals, timelines, outcomes, and evidence with your healthcare providers. 33:00 – Chronic Disease, Inflammation & Longevity The team reflects on cardiovascular disease, metabolic health, and optimizing long-term wellness. 33:59 – Final Thoughts A closing message on self-advocacy, partnership with healthcare providers, and the value of a functional medicine approach. Resources Mentioned Table Talk Podcast — Resources & Links The PharmToTable Team – Functional Medicine Providers Therapeutic Approaches Discussed Functional Medicine Integrative Medicine Lifestyle Medicine Food as Medicine Mediterranean Diet Elimination Diet Detox Diet Acupuncture Physical Therapy Intermittent Fasting Anti-Inflammatory Nutrition Health Tools & Assessments Continuous Glucose Monitor (CGM) Medical Symptom Questionnaire (MSQ) Food Sensitivity Testing Stool Testing / Gut Microbiome Analysis Organizations & Institutions PharmToTable Long Island University Thomas Jefferson University Hospital Medications Mentioned Prednisone Statins Biologics (general discussion) Antidepressants / Psychiatric Medications (general discussion) Supplement Spotlight Vitamin D / K2 Liquid - 1 fl oz Purchase Today D3 5000 with K2 60 Softgels Purchase Today
In this episode of FOMO Sapiens, Patrick McGinnis sits down with Geoff Cook, CEO of Noom, the leading digital health platform combining psychology, technology, coaching, and clinical care. Geoff co-founded The Meet Group, a NASDAQ-listed social entertainment company he led for 18 years through its $500 million sale, before joining Noom to tackle something bigger: the full picture of human health. The conversation gets into why GLP-1s are only as effective as the habits built around them, what the real data shows about weight regain after discontinuation, how Noom's behavior change stack actually works, and why microdosing is quietly becoming one of the most interesting developments in preventative health. Geoff also shares why he started microdosing himself, what it did to his running habit and A1C, and how AI is making it possible to deliver genuinely personalized health guidance at scale for the first time. Learn more about your ad choices. Visit megaphone.fm/adchoices
Doctor Mau Informa ®️ #drmauinforma Durante medio siglo, la endocrinología consideró al glucagón como el "villano" del metabolismo: la hormona responsable de subir el azúcar en la sangre. Sin embargo, ¿qué pasaría si pudiéramos domesticar a este villano para activar la quema extrema de grasa de forma segura. En este episodio de Doctor Mau Informa, analizamos la fascinante evolución científica que nos llevó desde tumores pancreáticos hasta el desarrollo del Retatrutide, un revolucionario fármaco "triple agonista". Descubre cómo la ciencia logró combinar tres señales hormonales (Glucagón, GLP-1 y GIP) en una sola inyección semanal para alcanzar resultados de pérdida de peso metabólica que antes solo le pertenecían al bisturí de la cirugía bariátrica. En este episodio aprenderás: → La balanza de la pérdida de peso: Por qué los medicamentos anteriores solo te quitaban el hambre, y cómo la nueva generación también acelera tu gasto energético. → El secreto del Glucagón: Cómo esta hormona del ayuno saca la grasa del hígado y eleva el metabolismo. → La evolución del GLP-1: El papel protector de la insulina natural para contrarrestar el azúcar y permitir una pérdida de peso segura. → Cirugía vs. Fármacos: Por qué los resultados de los nuevos tratamientos crónicos están cambiando el paradigma médico para siempre. → La realidad clínica: Efectos secundarios, la importancia de la titulación médica y por qué esto no es una "dieta milagro".
If you've ever thought, “I know what to do, so why can't I do it,” this conversation hits the nerve and gives you a way out. We sit down with Dr. John Oberg, a human behavior strategist and healthcare innovator whose work targets one of the biggest problems in modern health: chronic metabolic disease and type 2 diabetes. Along the way, John shares a near-death car crash story that reshaped how he sees faith, relationships, and service, and why that personal turning point connects directly to how people change when the stakes are real.We get concrete about what actually moves the needle: how hemoglobin A1C works, why tiny sustainable swaps can drive major blood sugar improvement, and why most “go hard on Monday” plans collapse under stress. John breaks down his core framework: focus on what you control (your thoughts and your actions), build small habits you can repeat, and create the right support system so your environment stops fighting you. We also talk GLP-1 medications, insulin, and modern telemedicine, not as magic fixes, but as tools that can help patients stabilize, lower treatment burden, and eventually reduce dependence on medication with food-as-medicine strategies.You'll also hear practical guidance you can use today: “move right” by shifting from processed food toward whole food, “move more” with 10-minute blocks of intentional walking, and stop grazing all day so your body gets clear fed and fasting periods. We even share a blunt, compassionate patient story framed as Door A, Door B, or Door C that shows what non-judgmental care really looks like when someone feels stuck.If this helped you, subscribe, share it with a friend who needs hope, and leave a review so more people can find these conversations. What's one small change you're willing to start this week?Join the What if it Did Work movement on FacebookGet the Book!www.omarmedrano.comwww.calendly.com/omarmedrano/15min
It's In The News - a look at the top diabetes stories and headlines happening now! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Episode transcript: fall Detroit and Seattle. Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells. The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings. XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. -- Back to the news.. XX Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology. -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings. XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition
Argelis Milian Robles was diagnosed with Type 1 diabetes in 2025 — alone, without a car, on the brink of losing her job, and managing celiac on top of it all. And that was just the beginning. What came next tested everything she had. Her faith. Her will to stay. Her relationship with her own body.In this episode, Argelis opens up about the moments that brought her to her lowest point and what it actually took to start building a life she wanted to live… one that includes pancakes, boba, and yellow curry. It's a story about learning to trust yourself when everything falls apart at once.WHAT WE COVER:The Sunday morning church visit that ended in the ICU with a blood sugar of 407What a pituitary brain hemorrhage six months into T1D changed about her insulin resistance, her mental health, and what she wanted for her lifeHow celiac prepped Argelis to drop her A1C from 13.9 to 5.4 in eight months, and why she doesn't recommend itWhy pancakes, boba, and yellow curry became the goals that mattered most in coachingThe two pages Argelis wrote after the brain hemorrhage that changed the direction of her lifeWHAT'S NEXT:
What Causes Cancer? The Truth Most Doctors Don't Talk AboutIn this episode of Intellectual Medicine, Dr. Stephen Petteruti explores the relationship between cancer, metabolism, sugar, insulin, body fat, and prostate cancer progression. He discusses the Warburg theory, which suggests that cancer may begin with dysfunctional mitochondrial metabolism, and compares it with the later focus on genetic causes of cancer. While he argues that the idea of “starving cancer” by eliminating sugar is too simplistic, he also emphasizes that metabolic health plays a real role in cancer risk and progression.The episode focuses heavily on prostate cancer, which Dr. Petteruti describes as unique compared with other cancers. He argues that conventional approaches often overlook the environment in which cancer develops, including excess body fat, high insulin, elevated blood sugar, inflammation, and poor metabolic health. He also discusses tests such as fasting insulin, hemoglobin A1c, and continuous glucose monitoring, as well as the importance of nutritional and behavioral change. The episode closes with a warning against extreme diets, oversimplified supplement advice, and one-size-fits-all cancer theories.Timestamps:(00:00) What Causes Cancer?(01:02 )The Warburg Theory(02:14) Genetics vs. Metabolism(04:22) Why “Starving Cancer” Is Too Simplistic(05:42) Body Fat, Insulin, and Prostate Cancer(08:30) Tests That May Help Assess Metabolic Health(10:47) Food, Weight Loss, and Cancer Risk(13:42) The Anti-Cancer Lifestyle(15:04) Toxins, Viruses, and Parasites(16:15) NAD, Mitochondria, and Supplement Caution(17:33) Growth Hormone, IGF-1, and Cancer Risk(19:12) Why Extreme Dieting Is Not the AnswerEnjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Book: Fight Cancer Like a Man: https://tinyurl.com/FightLikeAManBookDr. Steve's email newsletter: https://drstephenpetteruti.substack.com/subscribePodcast show notes : https://www.intellectualmedicine.com/podcast-notesMember exclusive content: https://tinyurl.com/DrPetterutiMemberLearn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:Instagram: https://www.instagram.com/dr.stephenpetteruti/ Facebook: https://www.facebook.com/dr.stephenpetteruti Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.
In this episode of the TCOYD Podcast, Dr. Edelman and Dr. Pettus are joined by pediatric endocrinologist Dr. Jamie Wood, medical director of pediatric diabetes at Rainbow Babies & Children's Hospital and an investigator on the INHALE-1 trial, to talk through inhaled insulin in kids and where it fits in real-world pediatric care.The conversation focuses on the recent approval of Afrezza for children as young as six, and what the INHALE-1 trial actually showed. Dr. Wood walks through the study design, A1C results, lung-function and safety data, and the practical aspects of dosing inhaled insulin in a pediatric population. Rather than positioning it as a replacement for injections or pumps, the discussion centers on finding the right fit for each child's needs, from the newly diagnosed kid with a needle phobia to the teen trying to dose discreetly during a 20-minute school lunch.Dr. E, Dr. P, and Dr. Wood also discuss the everyday realities that shape how this option is used, including the set-dose cartridge sizes, a titration approach refined in clinic, and how families are mixing and matching tools alongside automated insulin delivery. The takeaway is encouraging: there are more options than ever for managing mealtime insulin in kids, and this one may help fill some of the gaps left by injections and pumps.Key Topics • The recent approval of inhaled insulin for children as young as six • How the INHALE-1 pediatric trial was designed • A1C results and what the primary endpoint analysis showed • Continuous glucose monitor (CGM) metrics across the two groups • Lung-function (FEV1) monitoring and pediatric safety • Weight and body mass index (BMI) findings • Why mealtime dosing is a leading unmet need in pediatric type 1 diabetes (T1D) • The set-dose cartridge approach and how it reframes meal sizes • A real-world titration method for inhaled insulin • Managing cough and other practical considerations • Needle phobia and the kids who struggle most with injections • Using inhaled insulin alongside automated insulin delivery (AID) systems • What's coming next, including a smaller cartridge dose and a new-onset trial Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★
Most of us have had that moment where we get our bloodwork back and shake our heads. We're still our active, health‑minded selves and out of nowhere—rising LDL, ApoB, A1C, and maybe blood pressure and Lp(a), too. This week, preventive cardiology dietitian Michelle Routhenstein joins us to unpack the cardiometabolic chaos and what's really driving it. She explains estrogen's protective role in lipids and blood pressure, why standard risk calculators and even calcium scores can miss women's disease, and which advanced labs are worth asking for. We also dig into how under‑fueling and low‑carb diets can worsen cardiometabolic health and plaque; why complex carbs, fiber, fermented foods, and gut health matter so much; and how to approach protein, red meat, electrolytes, nitric oxide, and statins in a personalized, empowering way—remembering that 80–90% of heart disease remains preventable when women get the right information and advocate for themselves.Michelle Routhenstein, MS, RD, CDCES, CDN is a preventive cardiology dietitian and founder of Entirely Nourished, a virtual practice focused on personalized, science-based nutrition for heart health. With over 14 years of experience, she helps people improve cardiometabolic risk and manage conditions like atherosclerosis, heart failure, and atrial fibrillation using a whole-person approach. She holds Bachelor's and Master's degrees in Clinical Nutrition from New York University, serves on the Forbes Health Advisory Board and the Medical Advisory Committee for the National Menopause Foundation, and is the author of The Truly Easy Heart-Healthy Cookbook and Simple Meal Solutions for High Blood Pressure. Her work has been featured in outlets including Forbes Health, Fox News, Prevention, Women's Health, and Good Housekeeping, and she works with clients virtually from New York via www.entirelynourished.comJoin us at Feisty Fest September 18-20, 2026: https://feisty.co/events/feisty-fest/Sign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/Learn More about our 2026 Feisty Events, including Bike Camps and Cycling Trips: https://feisty.co/events/Follow Us on Instagram:Feisty Menopause: @feistymenopauseHit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Previnex: Get 20% off your order with code FEISTYBRAIN at https://www.previnex.com/ Wahoo: Use the code FEISTY2026 to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/WVhdrCozy Earth: Use Code HITPLAY at https://cozyearth.com/ for up to 20% off
Dr. Spencer and Karl Nadolsky sit down with David W, a nurse practitioner and one of the actual patients enrolled in the Triumph 1 retatrutide phase 3 trial, to break down the data that was just presented at the American Diabetes Association conference and explain why everyone in obesity medicine is paying very close attention. In this episode they cover what retatrutide actually is and why adding glucagon agonism to the GLP-1 and GIP dual agonism of tirzepatide creates a meaningfully different drug with direct effects on liver lipid metabolism, insulin sensitivity, blood pressure, and fat catabolism that you do not see with semaglutide or tirzepatide alone, what David's personal experience in the 12 milligram arm looked like from dose escalation through steady state including the GI side effects that faded by month seven and the heartburn that a low dose PPI fixed quickly, how David went from 240 pounds and a BMI of 35 down to 167 pounds by the end of the trial representing roughly 30 percent weight loss which is right at the trial average, what the Triumph 1 obesity trial found at 80 weeks with the nine and 12 milligram doses delivering nearly 26 and 28 percent average weight loss respectively and almost half of patients on the highest dose losing 30 percent or more, why the 104 week extension data showing patients who stayed on 12 milligrams reaching 30.3 percent average weight loss is being compared to bariatric surgery outcomes, what the Transcend type 2 diabetes trial showed with average A1C dropping to 5.9 percent on the 12 milligram dose in patients who were on no other diabetes medication, why the 41 percent triglyceride reduction and 20 percent LDL reduction are particularly interesting given that the mechanism appears to involve multiple pathways in the liver that tirzepatide and semaglutide do not touch, what the 70 percent reduction in WOMAC knee arthritis pain scores and 60 percent reduction in sleep apnea events mean for patients who have been told their only option is surgery, how Spencer plans to use retatrutide clinically once it is approved and which patients he thinks are the right candidates, why the gray market research peptide version currently circulating is something both doctors strongly advise against, and what Triumph 2 and Triumph 3 are measuring and when that data is expected. The Docs Who Lift podcast distills and simplifies the complexities of exercise, medicine, and weight loss. Subscribe so you never miss an episode. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company's 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.
Nurse practitioner Christine lived with Type 1 diabetes for over twenty years before realizing her early medical advice was flawed. She discusses unlearning bad habits, pregnancy, and lowering her A1C. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED or call 888-721-1514 Tandem Mobi ABLEnow save for today's needs or invest for tomorrow Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 20% at Cozy Earth Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Send Us Your Questions/CommentsA polygamous upbringing in Nigeria, a father's death at age seven, and a stretch of quiet atheism aren't the usual milestones on the road to church leadership, but that's exactly why Nonso Okpala's story is so gripping. We sit down as friends and church family and let him walk us through the moments that shaped his faith, from early Catholic devotion and seminary dreams to the slow, steady way God drew him back through Scripture, conviction, and surrender.Along the way, we talk honestly about hypocrisy, doubt, and what it feels like to keep showing up outwardly while your heart is drifting. Nonso shares how reading the Bible for himself challenged long-held assumptions, why prayer and fasting became practical tools in his fight for holiness, and how spiritual growth often looks more like a process than a single highlight moment. If you care about discipleship, sanctification, and learning to trust God when life feels complicated, this conversation goes there.Then the story turns into a true Nigerian immigrant testimony: scholarships, a visa, landing in the US with no safety net, and seasons of real financial hardship. You'll hear about unexpected provision, a stranger who became family, and the grit it took to excel academically on the way to becoming a CPA and professor. We also get personal about marriage, infertility, ectopic pregnancy, miscarriage, and the joy of twins, plus the health wake-up that led to a passion for nutrition, lifestyle change, and even helping his mom bring down A1C, blood pressure, and cholesterol.We close with the hard realities of corporate burnout, family medical crises, and the question that reset everything: “What do you have in your hand?” That clarity sparks purpose through ministry, media, and his book Prepare Now: 10 Practical Guides to Thriving and Surviving During Crisis. If you're encouraged, subscribe, share this with a friend, and leave a review so more people can find these stories of hope.New episodes every Mondaywww.lifehousemot.cominfo@lifehousede.comJoin us Sundays at 9 & 11 AMIntro music by Joey Blair
Most people think the cholesterol number on their lab report tells them whether their heart is at risk. But former National Lipid Association President Dr. Kevin Maki explains that LDL is just one piece of a much bigger picture and focusing on it alone can mean missing the markers that matter most.In this episode, Dr. Gabrielle Lyon sits down with Dr. Kevin Maki, former President of the National Lipid Association and co-editor-in-chief of the Journal of Clinical Lipidology, to discuss:Why ApoB and Lp(a) are better predictors of heart risk than LDL and why only about 2% of people ever get Lp(a) testedWhat a beef-vs-chicken feeding study revealed about red meat and cholesterol (the LDL results came back identical at 112 mg/dL)The evidence behind the seed oil debate, including why higher linoleic acid levels tracked with lower inflammation markers across a 2,000-person datasetWhy the balance of cholesterol-raising and cholesterol-lowering foods matters more than saturated fat aloneThe simple "ABCs" framework: A1c, blood pressure, cholesterol - for actually lowering long-term cardiovascular riskBy the end, you'll know which numbers actually predict heart risk, which tests to ask your doctor for, and how to cut through the conflicting noise around fat so you can make evidence-based decisions for the long haul.Thank you to our sponsors:OneSkin - Get 15% off at https://bit.ly/4tZnOpk with code DRLYONBodyHealth - Use the code LYON20 to get 20% off your first order https://bit.ly/48SJ7AC Amp - Visit https://bit.ly/3RcmqBz to get your AI-powered at-home gym for smarter, personalized training.Explore More from Dr. Gabrielle LyonPremium Podcast Subscription: Ad-free episodes, key takeaway summaries, exclusive Q&A, and behind-the-scenes content https://foreverstrong.supercast.comWeekly newsletter: Recipes, podcast updates, and practical weekly insights https://drgabriellelyon.com/sign-up/Apply to become a patient: Personalized care with Dr. Lyon's clinical team https://drgabriellelyon.com/new-patient-inquiry/Find Dr. Kevin Maki at:Midwest Biomedical Research: https://www.mbclinicalresearch.com/ LinkedIn: / kevin-c-maki-phd-497ba34 Connect with Dr. Gabrielle Lyon:Instagram: https://www.instagram.com/drgabriellelyon/TikTok: @drgabriellelyon X (Twitter): https://x.com/drgabriellelyonFacebook: https://www.facebook.com/doctorgabriellelyon Chapters00:00 - Introduction00:31 - Dr. Kevin Maki and the National Lipid Association01:04 - New dietary guidelines and the LDL confusion02:04 - What raises and lowers LDL cholesterol03:51 - Cholesterol levels from birth through puberty05:11 - The lipid panel kids should get before age 1106:42 - Lp(a): the test only 2% of people get08:18 - ApoB and the three risky particle types11:35 - Do we have evidence for "lower is better"?14:09 - The FLASH-GLICK risk factor framework17:10 - The 10% saturated fat guideline explained19:36 - Many dietary patterns can be healthy24:50 - Beef vs. chicken: identical LDL results27:10 - The balance of fatty acids that matters29:24 - Olive oil vs. corn oil feeding study31:00 - Lower for longer: 40-year risk reduction34:15 - Genetic cholesterol disorders and risk40:33 - The omega-3 index and why it matters49:10 - Are seed oils really driving inflammation?53:11 - How seed oils are processed and refined1:07:48 - Inherited beliefs and outdated nutrition science1:08:54 - Butter vs. cheese and high-fat dairy surprises1:14:48 - Exercise effects on HDL and triglycerides1:21:20 - The ABCs of reducing cardiovascular riskIf you found this episode valuable, share it with someone who would benefit from it.Disclaimers: This episode includes paid sponsorships.The Dr. Gabrielle Lyon Podcast and YouTube are for general information purposes only and do not constitute the practice of medicine, nursing, or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast, YouTube, or materials linked from this podcast or YouTube is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professional for any such conditions.
Sandi Peiffer has been happily married to her husband Corey for 39 yrs. She is a 61-year-old mother of 4 (ages 21-34) and grandmother of 3 (ages 6, 4, and 3 months… and #4 due in October!) who lives on the Atlantic coast of Florida. She is a retired homeschool mom of 26 years. She enjoys walking, resistance training, reading, crafting, cooking and spending time with her family. As an adult, Sandi has tried most of the diets we have all heard of… Weight Watchers, Susan Powter Stop the Insanity, TOPS, The Zone Diet, 40-30-30, Shake diets, Suzanne Somers “Somersize”, South Beach, Atkins, The Rosedale Diet, etc. Her real struggle with weight started when she went on an antidepressant for anxiety. Then the pounds really started to pack on. 120 lbs by the time it was all said and done. She found intermittent fasting after a diagnosis of Type 2. Diabetes with an A1C of 8.4 and a fasting glucose of 237. Starting IF in Dec. 2018, at 5'4” and 300 lbs. In this episode, she explains her IF journey over the past 7.5 yrs and the addition of peptides to her health journey. Her current weight is 170 lbs, her fasting glucose is 87, and her A1C is 4.8! At the end of the episode, she says she will mention some reference tools here:Youtube:Dr Tyna MooreThe DownsizedOn the PenDr Spencer Nadolsky Book:Weightless by Dr Rocio Salas-WhalenEnough: Your health, Your Weight and what it's like to be free by Ania M. Jastreboff, MD, Ph.D and Oprah WinfreyHow to connect with Graeme Join Graeme's Patreon and get accountability and support.www.patreon.com/thefastinghighwayWebsite to book a one-on-one call.www.thefastinghighway.com.To buy the book The Fasting Highway your local Amazon store, or any good online book seller. Disclaimer -The views in this podcast are those of the guest and host only and should not be taken as direct medical advice. Please consult your health professional before beginning any health plan.
Show Notes: Lilly Minkove shares her background in brand and strategy consulting, focusing on retail, beauty, and wellness. She discusses her time at McKinsey, Tapestry, and Louis Vuitton, emphasizing her work in the luxury sector. Lilly explains her transition from the corporate world to running ArtLogica Group, a boutique consulting practice focused on customer insights. Introduction to HeraSphere Lilly talks about her interest in health and wellness, which eclipsed her work in retail and luxury. She recounts attending a longevity talk by Dr. Darshan Shah, which sparked her interest in tracking biomarkers and consumer insights. Lilly describes the inception of HeraSphere, a women's health newsletter translating healthcare innovations into plain English. She highlights the importance of women's health, especially for those in perimenopause or menopause, and how her consulting experience translates to this new focus. The Five Pillars of Health Lilly outlines the five pillars of health: exercise and muscle, sleep, nutrition, brain health, and connection. She emphasizes the importance of strength training, noting that muscle is an anti-aging metabolic organ. She discusses the benefits of muscle, including anti-inflammatory proteins, insulin resistance, and bone density protection. The Critical Role of Sleep Lilly explains the critical role of sleep in brain function, immune system, and overall health. She discusses the importance of regularity and quality of sleep, noting that even one night of sleep deprivation can significantly impact natural killer cell activity. Lilly shares tips for improving sleep quality, such as maintaining a consistent sleep schedule, avoiding alcohol, and using a sleep tracker. The conversation turns to the impact of stress and anxiety on sleep and the importance of winding down before bed. The Impact of Sugar on the Body Lilly highlights the negative effects of sugar on the body, including inflammation, cardiovascular disease, and diabetes. She explains the concept of glucose spikes and how eating fiber, protein, and fat before carbohydrates can reduce their impact. Lilly emphasizes the importance of a diverse diet, recommending consuming 30 different types of plants and vegetables weekly and highlights the challenges of hidden sugars in processed foods. Maintaining Brain Health Lilly discusses the significance of brain health, noting that the brain consumes 20% of daily calories and requires continuous stimulation. She shares her experience with learning a new skill, cardio dance, and how it improves muscle memory and cognitive function. Lilly explains the link between midlife decisions and cognitive outcomes, emphasizing the importance of lifestyle measures in preventing Alzheimer's. Lilly elaborates on the benefits of keeping the brain active through learning and new skills. Community and Health Connection Lilly highlights the importance of social connections for overall health, citing a Harvard study on the mortality risk of social isolation. She discusses the decline of extended family households and the need for intentional efforts to maintain social connections. Lilly emphasizes the role of small interactions with people in the community in reducing loneliness and improving well-being. Lilly discusses the benefits of having a support system and the impact of feeling less isolated on health outcomes. The Complexity of the Wellness Industry Lilly explains her dual objectives: sharing knowledge with consumers and using consumer insights to inform her consulting practice. She offers services to help brands distill what their customers want and convey value effectively. Lilly highlights the complexity of the wellness industry and her expertise in understanding the female consumer. Measuring Health KPIs Lilly outlines key health metrics, starting with blood pressure and hemoglobin A1C, which measure metabolic efficiency and cardiovascular risk. She discusses C-reactive protein (CRP) as an indicator of systemic inflammation and its association with various diseases. Lilly explains fasting insulin and LDL cholesterol, noting their importance in measuring insulin resistance and cardiovascular health. She highlights the importance of bone density and body composition, recommending DEXA scans for accurate measurement. A Focus on Longevity Lilly discusses VO2 max, a measure of cardiovascular capacity and longevity, and the challenges of obtaining accurate measurements. She mentions the use of fitness trackers to estimate VO2 max and the benefits of regular monitoring. Lilly shares her personal practice of conducting twice-yearly health panels to track biomarkers and ensure overall well-being. Timestamps: 02:47: Transition to Women's Health and HeraSphere 06:48: Key Health Pillars: Exercise and Muscle 13:57: Sleep and Its Importance 23:57: Nutrition and Sugar Impact 29:53: Brain Health and Lifelong Learning 36:20: Connection and Social Support 38:32: Lilly's Services and Consumer Insights 41:08: Key Performance Indicators (KPIs) for Health 47:04: Advanced Health Metrics and Longevity Links: HeraSphere newsletter: https://herasphere.beehiiv.com/ HeraSphere website: https://herasphere.beehiiv.com/p/herasphere-24-become-the-ceo-of-your-health Consulting practice website: https://artlogicagroup.com/ This episode on Umbrex: Unleashed is produced by Umbrex, which has a mission of connecting independent management consultants with one another, creating opportunities for members to meet, build relationships, and share lessons learned. Learn more at www.umbrex.com. *AI generated timestamps and show notes.
What if the thing you want most is actually the solution, not the problem? Dr. Kristine Goins was a full time academic psychiatrist, burnt out, physically unwell, and working across nine clinics with five different electronic medical record systems. Two years out of residency she booked a one way ticket to Colombia and never looked back. She now works one clinical day a week, lives in her 16th country, and helps other physicians do the same. Timestamps: 1:00: Two years out of residency, chest pains, tremors, and a skyrocketing A1C. What burnout actually looked like 4:00: Nine clinics, five different systems, and notes every weekend. What her academic career really cost her 9:00: Why her colleagues stayed even though they were miserable. The devil you know 16:00: How NomadMD started and why there is no specialty that cannot be digitized 22:00: Working two days a week from Colombia and earning more than she did full time in academia 25:00: The one hour a week that changed everything and how to stop catastrophizing your way out of a better life 3 Key Takeaways: Your Body Will Tell You What Your Mind Is Trying to Ignore. Dr. Goins was eating well, doing yoga, and doing all the right things. Her body still gave her tremors, chest pains, and a skyrocketing A1C. Burnout is not a mindset problem you can outrun with self care. It is a signal that something structural has to change and the sooner you listen the better. The Stability You Think You Have May Be Costing You More Than You Know. Working full time in academia felt safe. It was also paying her less than two days of direct contract work from Colombia. The institution takes a cut, sets your schedule, and decides your worth. When you work for yourself, the math changes completely. Give Your Brain a Better Problem to Solve. Instead of asking how do I survive this, Dr. Goins started asking what if traveling was actually the path to financial independence? Our brains are wired to solve problems. The question is whether you are giving yours a problem worth solving. Sometimes the thing you want most is not the obstacle. It is the answer. Connect with Dr. Kristine Goins:
Fifty-year type 1 veteran and health psychologist Dr. Beth Braun discusses managing diabetes burnout, overcoming food shame, and the clinical impact support groups have on lowering A1C. ABLEnow save for today's needs or invest for tomorrow Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof. ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. If the podcast has helped you to live better with type 1 please tell someone else how to find it!
Almost half of all heart attacks are silent heart attacks, which means there are no warning signs. Fortunately, your hands can reveal heart disease warning signs that could save your life. Discover the key health markers, like weak grip strength or clubbed fingers, that can provide important insight into your cardiovascular health.
***JOIN THE NEXT MASTER YOUR FASTING CHALLENGE THAT STARTS June 10th, 2026!*** We'll GUIDE you on how to FAST to LOSE FAT for good, and use ‘fast cycling' to achieve uncommon results! REGISTER HERE! Click the link for DATES, DETAILS, and FAQs! In this research-backed episode, Dr. Scott Watier and Tommy Welling break down a gold-standard meta-analysis comparing the most popular intermittent fasting protocols head-to-head — time-restricted eating, alternate day fasting, and the 5:2 method — against traditional calorie restriction to see which approach actually moves the needle on blood sugar and insulin resistance. The hosts cut through the complexity to deliver a clear takeaway: time-restricted eating consistently wins for improving fasting glucose and A1C, while alternate day fasting is the most powerful tool for directly lowering insulin resistance and fasting insulin levels — the upstream markers that determine whether your body is stuck in fat-storing mode or freed up to burn. They also tackle the real-world gaps the research can't capture — the simplicity, food noise reduction, and decision fatigue relief that make fasting dramatically easier to sustain long-term compared to the slow grind of calorie counting. Listeners will come away knowing exactly how to match the right fasting tool to their current situation, whether the goal is better lab numbers, breaking through stubborn weight loss resistance, or building a flexible lifestyle that doesn't require restarting every Monday. The episode closes with a straightforward reminder that consistency in a foundational fasting window will always outperform an aggressive protocol done halfway — and that fasting wins not by being perfect on paper, but by being livable in real life. Take the NEW FASTING PERSONA QUIZ! - The Key to Unlocking Sustainable Weight Loss With Fasting! Resources and Downloads: SIGN UP FOR THE DROP OF THE ULTIMATE GUIDE TO BLOOD SUGAR CONTROL GRAB THE OPTIMAL RANGES FOR LAB WORK HERE! - NEW RESOURCE! FREE RESOURCE - DOWNLOAD THE NEW BLUEPRINT TO FASTING FOR FAT LOSS! SLEEP GUIDE DIRECT DOWNLOAD DOWNLOAD THE FASTING TRANSFORMATION JOURNAL HERE! Partner Links: Get your FREE BOX OF LMNT hydration support for the perfect electrolyte balance for your fasting lifestyle with your first purchase here! Get 25% off a Keto-Mojo blood glucose and ketone monitor (discount shown at checkout)! Click here! Our Community: Let's continue the conversation. Click the link below to JOIN the Fasting For Life Community, a group of like-minded, new, and experienced fasters! The first two rules of fasting need not apply! If you enjoy the podcast, please tap the stars below and consider leaving a short review on Apple Podcasts/iTunes. It takes less than 60 seconds, and it helps bring you the best original content each week. We also enjoy reading them!
Click to Send us a text!We challenge the idea that constant snacking boosts metabolism and explain how all-day grazing can keep insulin elevated and slowly erode energy, focus, and recovery in motorsports. We translate insulin resistance into real race-day consequences and lay out a clearer plan for meal rhythm, testing, and metabolic flexibility. • why “always fed” habits can create subtle crashes and brain fog • what insulin does and how chronic elevation leads to insulin resistance • common race weekend fueling patterns that keep glucose spiking • why context matters for athletes and why fasting is not for everyone • performance costs in motorsports like slower decisions and slower recovery • early detection with hemoglobin A1C and advanced at-home testing • using a CGM to see food, stress, sleep, and travel effects in real time • practical anchors like the 30/ 10/ 3 rule, strength training, sleep, and stress reduction • post-meal movement to rebalance blood sugar fast be sure to click that subscribe button so you never miss an episode. If you're serious about optimizing performance at the root level, you can apply to work with Victory Lane Wellness at victorylanewellness.com Support the showAs a token of gratitude, of course you're interested in these FREE and powerful resources, and because you enjoy the show, first be sure to leave your 5-STAR Review HERE!
How can you lift weights, build muscle, and still be insulin resistant? What if your metabolism is sending warning signs before your A1C ever changes?Insulin resistance is often treated like a weight loss or carb problem, but Amber Wilhoit, a registered dietitian and diabetes specialist with 22 years of clinical experience, shows why muscle quality, visceral fat, fiber, sleep, stress, and daily movement all matter.We talk about fasting insulin, waist-to-hip ratio, post-meal walks, strength training, and why midlife hormone health can shift body composition even when your effort stays the same. You'll learn how to lose fat, build muscle, and protect your metabolism with evidence-based nutrition and fitness strategies that go beyond “just lift more.”Join Eat More Lift Heavy, the 26-week fat loss program for adults over 40 where you learn the skills to improve your insulin sensitivity, build muscle, eat a flexible diet full of protein and carbs, and improve your sleep, stress, and movement... one week at a time so it's sustainable and you FINALLY keep the fat off for good.Timestamps:0:00 - Why muscle may not fix insulin2:39 - Visceral fat and waist-to-hip6:26 - Fasting insulin, the underused test10:06 - Exercise pathways, stress, and sleep18:52 - Protecting muscle during fat loss21:08 - Perimenopause shifts and visceral gain26:53 - Stop over-restricting nutrition34:28 - Sexual health as metabolic signal39:04 - Fiber, gut health, and glucose controlEpisode resources:Website: Empowered Diabetes Podcast: The Diabetes Podcast®YouTube: @TheDiabetesPodcast Instagram: @empowereddiabetes
Jay Campbell is BACK... and this time he's talking about all the cutting edge peptides for building muscle. We're talking follistatin derivatives with 19 day half lives, super retatrutide that you might only need to inject once every TWO MONTHS, and why these compounds could be the future of building lean mass without the brutal side effects. Jay tells stories about the legendary Dan Duchaine. You'll learn the REAL history of cyclical ketogenic dieting, why going zero carb all week then carb loading on weekends was revolutionary for bodybuilders in the 90s. Here's where it gets controversial... Jay explains why aromatase inhibitors are absolutely DESTROYING modern bodybuilding physiques. SPONSORS Huel — huel.com/mindpump MP Hormones — mphormones.com MAPS PPL — mapsppl.com KEY TOPICS • Cyclical ketogenic dieting protocol: zero carb Monday through Friday, depletion workout Saturday morning, then unlimited carbs until Sunday night • Long term ketogenic dieting can retard insulin metabolism and increase A1C levels even without eating carbs • Aromatase inhibitors prevent bodybuilders from achieving true shredded condition by blocking fat loss below 7 to 8% body fat • Estrogen ratio to testosterone matters more than absolute estrogen levels for men on TRT • New follistatin derivative FLGR has a 19 day half life and binds only to non organ sensitive androgen receptors • Super retatrutide may only require injection once every two months due to extended efficacy • Dan Duchaine pioneered the ephedra caffeine aspirin stack and introduced carb cycling to bodybuilding • High dose insulin combined with carbohydrate manipulation was the real secret of 90s mass monster physiques TIMESTAMPS 0:24 Jay Campbell 1:42 Dan Duchaine 5:21 The cyclical ketogenic diet 6:26 crash test dummy research 7:52 long term keto 9:21 carb loading protocol 11:54 Insulin resistance symptoms 14:26 Why AIs are destroying physiques 18:58 New follistatin FLGR peptide 27:15 Recovery Stack 32:46 Bio Regulators and Prostate Peptides 35:33 Legal Gray Area 39:48 Company Operations Explained 40:38 New Hair and Face Launch 41:41 GLP Patent Crackdown 44:07 Small Molecules 45:29 Microdosing GLP Side Effects 48:40 Antitrust and Innovation Fears 51:09 Bodybuilding 52:50 Klotho Anti Aging Breakdown 59:42 Cerebrolysin Brain Benefits 01:07:13 Jail Story 01:16:11 Product Timeline PEOPLE MENTIONED Jay Campbell — Guest and peptide expert who specializes in cutting edge hormone optimization Dan Duchaine — Legendary bodybuilding guru who wrote The Underground Steroid Handbook and pioneered the ECA stack and carb cycling Mauro DiPasquale — Doctor who wrote The Anabolic Diet book and was instrumental in low carb bodybuilding research Lyle McDonald — Author of the cyclical ketogenic diet book who Jay describes as brilliant but crazy Hans Hobstock — Bodybuilder who appeared on the cover of Dan Duchaine's Body Opus book and trained at Jay's gym Ben Pakulski — Professional bodybuilder who described aromatase inhibitors as the worst drugs he ever took Charles Poliquin — Strength coach referenced for his quote about earning your carbs through training Paul Saladino — Carnivore diet advocate who changed his position to include honey and fruit